Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$0.7 - $1.58 $131,197 - $296,131
-187,425 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$0.48 - $2.19 $83,780 - $382,249
174,543 Added 1354.94%
187,425 $133,000
Q4 2018

Feb 07, 2019

BUY
$1.6 - $3.68 $17,500 - $40,251
10,938 Added 562.65%
12,882 $46,000
Q3 2018

Oct 30, 2018

BUY
$2.3 - $4.95 $4,471 - $9,622
1,944 New
1,944 $5,000

About Cocrystal Pharma, Inc.


  • Ticker COCP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,122,420
  • Market Cap $17.9M
  • Description
  • Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...
More about COCP
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.